Trial Profile
Long term Stabilization of Polypoidal Choroidal Vasculopathy Lesions and Vision in Response to Injection of Intravitreal Ranibizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2018
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 27 Jul 2018 New trial record
- 01 Jun 2018 Results published in the Medicine